parsleyhealth.comHealthcare / Healthcare softwareFounded: 2015Funding to Date: $136.13MM
Parsley Health is a wellness and medical care company with a data-focused, holistic approach. Their subscription-based services offer personalized diagnostic management and health coach consultations to treat the root cause of chronic conditions. Parsley Health was founded by Joel Wishkovsky and Robin Berzin in 2016 and is headquartered in New York, New York.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/18/2023 | Series 1-B-2 | $2.3MM | $xx.xx | $209.7MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
963,432
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
12/18/2023 | Series 1-B-1 | $20MM | $xx.xx | $209.7MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
14,255,187
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
12/18/2023 | Series 1-A | $20MM | $xx.xx | $209.7MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
14,255,182
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
01/31/2023 | Series 2-C-2 | $4.8MM | $xx.xx | $310.03MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,349,788
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
01/31/2023 | Series 2-C-1 | $36MM | $xx.xx | $310.03MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,191,872
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
10/10/2019 | Series 2-B-1 | $18.2MM | $xx.xx | $130.52MM | White Star Capital, FirstMark Capital, Amplo, Alpha Edison, Arkitekt Ventures, Trail Mix Ventures, Galaxy Digita, Nat Turner, Tom Lee | |
Price per Share
$xx.xx
Shares Outstanding
5,117,959
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
White Star Capital, FirstMark Capital, Amplo, Alpha Edison, Arkitekt Ventures, Trail Mix Ventures, Galaxy Digita, Nat Turner, Tom Lee
|
||||||
10/10/2019 | Series 2-B | $21.97MM | $xx.xx | $130.52MM | White Star Capital, FirstMark Capital, Amplo, Alpha Edison, Arkitekt Ventures, Trail Mix Ventures, Galaxy Digita, Nat Turner, Tom Lee | |
Price per Share
$xx.xx
Shares Outstanding
7,280,340
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
White Star Capital, FirstMark Capital, Amplo, Alpha Edison, Arkitekt Ventures, Trail Mix Ventures, Galaxy Digita, Nat Turner, Tom Lee
|
||||||
03/30/2018 | Series 2-A-5 | $802,525 | $xx.xx | $41.27MM | FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa | |
Price per Share
$xx.xx
Shares Outstanding
743,079
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa
|
||||||
03/30/2018 | Series 2-A-4 | $1.21MM | $xx.xx | $41.27MM | FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa | |
Price per Share
$xx.xx
Shares Outstanding
1,345,314
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa
|
||||||
03/30/2018 | Series 2-A-3 | $202,559 | $xx.xx | $41.27MM | FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa | |
Price per Share
$xx.xx
Shares Outstanding
281,332
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa
|
||||||
03/30/2018 | Series 2-A-2 | $641,219 | $xx.xx | $41.27MM | FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa | |
Price per Share
$xx.xx
Shares Outstanding
1,424,932
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa
|
||||||
03/30/2018 | Series 2-A-1 | $10MM | $xx.xx | $41.27MM | FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa | |
Price per Share
$xx.xx
Shares Outstanding
5,829,391
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
FirstMark Capital, Amplo, Trail Mix Ventures, Combine, The Chernin Group. Dr. Mark Hyman, Nat Turner, Neil Parikh, Dave Gilboa
|